Skip to Content
Search All Programs & Services
Search by Name, Speciality, Program, or Research
Make a Donation
Make an Appointment
Ask a Question
Refer a Patient
Providers > Researchers > Donald Bellgrau
Immunobiology of autoimmunity and cancer. We are focused on the role of peripheral T cell regulation in the generation of autoimmunity and development of autoreactivity that might be of benefit as a tumor therapy. We are also studying a whole yeast based biologic.
Professor of Immunology and Medicine, Program Leader in Immunology/Immunotherapy
Bellgrau, D. 2005 Can getting excited over nothing provoke autoimmunity? Adv. Exp. Med. Biol. 552:311-6.
Lu, Y., Bellgrau, D., Dwyer-Nield, L.D., Malkinson, A.M., Duke, R.C., Rodell, T.C. and Franzusoff, A. 2004. Mutation-selective tumor remission with Ras-targeted, whole yeast-based immunotherapy. Cancer Research 64:5084-88.
Lang, J., Kominski, D., *Bellgrau, D. *Scheinman, R (*equivalent senior authors) 2004. Partial activation leads to premature death of T cells harboring an Ian gene mutation. Eur. J. of Immunology 34, 2396-406.
Modiano, J.F.; Sun, J., Lang, J., Vacano, G., Patterson, D., Chan, D.Franzusoff, A.,Gianani, R.,., Meech, S.J., Duke, R. and Bellgrau, D. 2004 Fas ligand dependent suppression of autoimmunity via recruitment and subsequent termination of activated T cells. Clinical Immunology 112:54-65.
Moore, J., Scheinman, R. and Bellgrau, D. 2001 The generation of a novel T cell activation state controlled by a diabetogenic gene. J. of Immunology 166:241-248.
Link to Faculty Publications
Link to PubMed for more papers
1980-1983: Member of the Scientific Staff, The Basel Institute for Immunology
Member Comparative Medicine Study Section Founding Scientist, GlobeImmune Inc
1400 Jackson St Denver, CO 80206 1.877.225.5654 Network of Locations Contact Us
© 2015 National Jewish Health Policies & Guidelines | My National Jewish Health